Medicine and Dentistry
Meibomian Gland
100%
Breast Cancer
63%
CD8 Antigen
62%
Follicular Lymphoma
50%
Endometrium
50%
Visual Analog Scale
50%
Biological Marker
48%
Chlordane
43%
Immunofluorescence
43%
Body Mass Index
38%
Interleukin-6
37%
Malignant Neoplasm
34%
Cancer Risk
34%
Breast Density
33%
Endometrial Cancer
31%
Cell Density
31%
Bariatric Surgery
31%
Cancer Risk Assessment
31%
Morbid Obesity
25%
Enlarged Vestibular Aqueduct
25%
Prognostic Factor
25%
Inner Ear Malformation
25%
Hearing Impairment
25%
Cross-Link
25%
Predictive Modeling
25%
Protein Expression
25%
Immunocompetent Cell
22%
Meibography
16%
Tissue Microarray
16%
Overall Survival
12%
Tumor Necrosis Factor
12%
Low Calorie Diet
12%
Mammography
11%
Mammogram
11%
Tumor Microenvironment
11%
Morphology
10%
Follicle
10%
Eosin
10%
Haematoxylin
10%
Breast Cancer Screening
8%
Transfer of Learning
8%
High Risk Population
8%
Cancer Risk Factor
8%
Glioblastoma
7%
Personalized Medicine
7%
Heidelberg Retinal Tomography
7%
Contralateral
7%
Odds Ratio
7%
Menopause
7%
Neoplasm
6%
Immunology and Microbiology
Prognostic Biomarker
68%
CD3 Antigen
56%
Immunofluorescence
54%
FOXP3
50%
Endometrium
50%
CD8
49%
CD68
38%
Interleukin-6
37%
Programmed Death-Ligand 1
29%
Cell Density
25%
Rituximab
25%
Mononuclear Phagocyte
25%
Squamous Cell
25%
Progression Free Survival
25%
Overall Survival
21%
Immunocompetent Cell
21%
CD4
20%
Monocyte
20%
Body Mass
18%
CD69
16%
Reed Sternberg Cell
16%
Macrophage
16%
Calorie
12%
Tumor Necrosis Factor
12%
CD8+ Cell
12%
Tumor-Associated Macrophage
12%
Immune Escape
10%
Survival Prediction
8%
Random Forest
8%
Lymphocyte
8%
Dendritic Cell
8%
Systemic Inflammation
6%
Immunosurveillance
6%
Immune System
6%
Tissue Section
6%
Immunotherapy
6%
Cell Interaction
5%
Cancer Immunotherapy
5%
Biochemistry, Genetics and Molecular Biology
Breast Density
50%
Immunofluorescence
38%
FOXP3
37%
CD8
30%
CD68
25%
Progression Free Survival
25%
Artificial Intelligence
25%
Menopause
25%
PD-L1
25%
Rituximab
25%
Protein Expression
25%
Cross-Link
25%
Transfer of Learning
25%
Breast Cancer Screening
25%
Artificial Intelligence
25%
High Risk Population
25%
Overall Survival
21%
Tissue Microarray
20%
CD4
20%
CD69
16%
DAPI
12%
Eosin
10%
Microarrays
8%
Survival Prediction
8%
Random Forest
8%
Tumor-Associated Macrophage
8%
Lymphocyte
8%
Cancer Immunotherapy
5%
Cell-Cell Interaction
5%
Clinical Study
5%
Immunocompetent Cell
5%